arginyl-glycyl-aspartic acid and Female Genital Neoplasms

arginyl-glycyl-aspartic acid has been researched along with Female Genital Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alvarez, RD; Aurigemma, R; Barnes, MN; Curiel, DT; Grizzle, WE; Harris, RD; Kimball, KJ; Kuo, H; Preuss, MA; Saddekni, S; Siegal, GP; Stockard, CR; Wan, W; Wang, M	1

Trials

1 trial(s) available for arginyl-glycyl-aspartic acid and Female Genital Neoplasms

Article	Year
A phase I study of a tropism-modified conditionally replicative adenovirus for recurrent malignant gynecologic diseases. Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Nov-01, Volume: 16, Issue:21 Topics: Adenoviridae; Aged; Aged, 80 and over; Cancer Vaccines; Carcinoma; Female; Genital Neoplasms, Female; Humans; Middle Aged; Oligopeptides; Oncolytic Virotherapy; Organisms, Genetically Modified; Recurrence; Tumor Cells, Cultured; Vaccines, DNA; Viral Tropism; Virus Replication	2010

Article

Year

A phase I study of a tropism-modified conditionally replicative adenovirus for recurrent malignant gynecologic diseases.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Nov-01, Volume: 16, Issue:21

Topics: Adenoviridae; Aged; Aged, 80 and over; Cancer Vaccines; Carcinoma; Female; Genital Neoplasms, Female; Humans; Middle Aged; Oligopeptides; Oncolytic Virotherapy; Organisms, Genetically Modified; Recurrence; Tumor Cells, Cultured; Vaccines, DNA; Viral Tropism; Virus Replication

2010